- Home
- SYRE vs LNC Comparison
SYRE vs LNC Comparison
Compare SYRE & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | LNC |
|---|---|---|
| Founded | 2013 | 1905 |
| Country | United States | United States |
| Employees | N/A | 9423 |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | LNC |
|---|---|---|
| Price | $101.32 | $46.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 16 |
| Target Price | ★ $85.08 | $43.13 |
| AVG Volume (30 Days) | 1.1M | ★ 2.1M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.60 |
| Revenue Next Year | N/A | $3.73 |
| P/E Ratio | ★ N/A | $7.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.51 | $32.18 |
| 52 Week High | $105.09 | $46.82 |
Technical Indicators
Market Signals| Indicator | SYRE | LNC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability, and dental.